These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 9074307

  • 1. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH.
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [Abstract] [Full Text] [Related]

  • 2. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH, Baxter LR, Rego J.
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [Abstract] [Full Text] [Related]

  • 3. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP, Gleiter CH, Möller HJ.
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [Abstract] [Full Text] [Related]

  • 4. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM, Masica DN, Heiligenstein JH, Wheadon DE, Zerbe RL.
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [Abstract] [Full Text] [Related]

  • 5. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
    Tulen JH, Volkers AC, van den Broek WW, Bruijn JA.
    J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
    [No Abstract] [Full Text] [Related]

  • 6. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA, Hoencamp E, Bouvy PF, Haffmans PM.
    Clin Neuropharmacol; 1993 Oct; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [Abstract] [Full Text] [Related]

  • 7. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M, Pilhatsch M, Bauer M, Köberle U, Ricken R, Janssen G, Ulrich S, Bschor T.
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [Abstract] [Full Text] [Related]

  • 8. [High dosage tranylcypromine treatment of "therapy refractory" depressions].
    Schmauss M.
    Nervenarzt; 1996 May; 67(5):390-3. PubMed ID: 9005348
    [Abstract] [Full Text] [Related]

  • 9. Monoamine oxidase inhibitors revisited: what you should know.
    Goldberg JF, Thase ME.
    J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352
    [No Abstract] [Full Text] [Related]

  • 10. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA.
    Ned Tijdschr Geneeskd; 2003 Oct 04; 147(40):1940-3. PubMed ID: 14574774
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The use of monoamine oxidase inhibitors in primary care.
    Culpepper L.
    J Clin Psychiatry; 2012 Oct 04; 73 Suppl 1():37-41. PubMed ID: 22951241
    [Abstract] [Full Text] [Related]

  • 15. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D, Silver JM, Opler LA.
    J Clin Psychopharmacol; 1989 Jun 04; 9(3):198-202. PubMed ID: 2738181
    [Abstract] [Full Text] [Related]

  • 16. [Rational use of antidepressants in general medicine].
    Verbanck P, Cnockaert P.
    Rev Med Brux; 1996 Sep 04; 17(4):224-9. PubMed ID: 8927850
    [Abstract] [Full Text] [Related]

  • 17. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT.
    J Am Geriatr Soc; 2007 Nov 04; 55(11):1890. PubMed ID: 17979910
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment with selective and reversible monoamine oxidase inhibitors in depressed patients: is there a biological effect proportional to the dose?].
    Radat F, Berlin I, Varoquaux O, Ferreri M, Puech A.
    Ann Med Psychol (Paris); 1996 Jun 04; 154(3):204-6. PubMed ID: 8766502
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Brofaromine in non-endogenous major depressed inpatients--results of a preliminary dose-finding trial versus tranylcypromine.
    Volz HP, Heimann H, Bellaire J, Laux G, Möller HJ.
    Pharmacopsychiatry; 1994 Jul 04; 27(4):152-8. PubMed ID: 7972347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.